Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about BAYER
02/16BAYER : fördert freiwilliges Mitarbeiter-Engagement seit zehn Jahren
PU
02/15BAYERNPV : Bayer receives first approval for Eylea in China
AQ
02/15BAYER : Syngenta aims to sell bonds within weeks, M&A important - CFO
RE
02/15BAYER : and Mitsui Chemicals Agro sign licence agreement for novel fungicide
PU
02/14BAYER : Gets FDA Warning Over Manufacturing Practices at German Site
DJ
02/14BAYER : gets FDA rebuke for drug production in Germany
RE
02/14GLOBAL EYE CANCER MARKET REPORT WITH : Global Eye Cancer Market - Global Industr..
AQ
02/14BAYERNPV : Bayer - New data for aflibercept show prolonged injection intervals
AQ
02/13BAYER : Taking Russia Antitrust Authorities to Court Over Monsanto
DJ
02/13CENTRAL NERVOUS SYSTEM DRUGS MARKET : Central Nervous System Drugs Market Overv..
AQ
02/10EU says Bayer Monsanto must not hurt competition in digital farming
RE
02/09GASTROINTESTINAL DRUGS MARKET GLOBAL : This consequently drives the global gastr..
AQ
02/08Bayer offers vegetable seeds disposal to clinch Monsanto deal - sources
RE
02/08BAYER : How Bayer achieved operational excellence in the lab
AQ
02/08SELF INJECTION DEVICE MARKET DEMAND, : Self Injection Device Market Overview & I..
AQ
More most relevant news
All news about BAYER
02/16BAYER : fördert freiwilliges Mitarbeiter-Engagement seit zehn Jahren
PU
02/15BAYER : Researchers Submit Patent Application, "Antibody and Protein Formulation..
AQ
02/15BAYER : Recent Findings in Pesticides Described by Researchers from Bayer (Refin..
AQ
02/15BAYERNPV : Bayer receives first approval for Eylea in China
AQ
02/15BAYER : Syngenta aims to sell bonds within weeks, M&A important - CFO
RE
02/15BAYER : and Mitsui Chemicals Agro sign licence agreement for novel fungicide
PU
02/14BAYER : Gets FDA Warning Over Manufacturing Practices at German Site
DJ
02/14BAYER : gets FDA rebuke for drug production in Germany
RE
02/14GLOBAL EYE CANCER MARKET REPORT WITH : Global Eye Cancer Market - Global Industr..
AQ
02/14BAYERNPV : Bayer - New data for aflibercept show prolonged injection intervals
AQ
More news
Sector news : Pharmaceuticals - NEC
02/18NOVARTIS : CEO Steers Drug Maker Back to R&D
DJ
02/16S&P 500 caps off strongest week in five years
RE
02/16ASTRAZENECA : U.S. FDA approves AstraZeneca's immunotherapy for lung cancer
RE
02/16NOVARTIS : readies to auction U.S. generic pills business - sources
RE
02/16Backstory - Warren Buffett's Valentine's Day surprise for investors
RE
02/16WARREN BUFFETT : Warren Buffett's Valentine's Day surprise for investors
RE
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
02/16Tracking David Einhorn's Portfolio - Q4 2017 Update 
02/15Tracking Warren Buffett's Berkshire Hathaway Portfolio - Q4 2017 Update 
02/14ROAD TO FINANCIAL INDEPENDENCE : My January 88-Stock Portfolio Review 
02/13Bayer sues Russian antitrust regulator in bid for more time in Monsanto case 
02/13YOUR DAILY PHARMA SCOOP : A Look At Celldex, BeiGene Data, Axovant Announces Cha.. 
02/12Bayer submits application in Europe for extended dosing interval for Eylea 
Latest Tweets
02/17Getting Bayer deal through has been hard work, so is rewarding CEO and other.. 
02/16KBR awarded multi-year engineering services contract for Covestro's North Ame.. 
02/16Bayer plant flagged by FDA for poor GMP practices: Biopharma Dive
1
02/16Covestro LLC becomes 'Official Innovation Partner of the Pittsburgh Penguins'.. 
02/152018 Xofigo (radium-223; Bayer) Drug Analysis: A Radioisotope that Kills Tumo.. 
More tweets
Qtime:259
Financials (€)
Sales 2017 35 346 M
EBIT 2017 7 428 M
Net income 2017 6 815 M
Debt 2017 8 806 M
Yield 2017 2,64%
P/E ratio 2017 13,63
P/E ratio 2018 18,28
EV / Sales 2017 2,55x
EV / Sales 2018 2,50x
Capitalization 81 487 M
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 121 €
Spread / Average Target 23%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER-6.36%100 998
JOHNSON & JOHNSON-7.19%352 552
NOVARTIS-3.37%224 301
PFIZER-2.84%212 857
ROCHE HOLDING LTD.-9.37%210 327
MERCK AND COMPANY-0.50%149 572